DERMATA THERAPEUTICS, INC. — Cash Flow Charts
9 quarters of history · ending 2023-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+36.7% +$958K
$-2M
Free Cash Flow↑+36.7% +$958K
$-2M
Financing Cash Flow↓-64.6% -$3M
$2M
Stock-Based Comp↓-44.2% -$104K
$131K
Debt Repaid
$12K
D&A
$0
SBC Allocated Expense↓-44.2% -$104K
$131K